Inovio Pharmaceuticals Inc. (NASDAQ: INO) Stock Information | RedChip

Inovio Pharmaceuticals Inc. (NASDAQ: INO) Listen to this Section


$7.84
+0.0400 ( +0.51% ) 229.4K

Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Market Data


Open


$7.84

Previous close


$7.80

Volume


229.4K

Market cap


$203.30M

Day range


$7.72 - $8.00

52 week range


$3.89 - $14.75

Insider Ownership Transactions

Total Amount Purchased: -26,356.00 | $ -206,631.04

Date Type Amount Purchased Purchaser
2024-05-13 Sale -1000.00 DANSEY ROGER D
2024-02-28 Sale -972.00 Weiner David B.
2024-02-28 Sale -1878.00 Shea Jacqueline Elizabeth
2024-02-28 Sale -1878.00 Humeau Laurent
2024-02-28 Sale -1878.00 KIES PETER
2024-02-28 Sale -18750.00 Sumner Michael John

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 May 16, 2024
4 Insider transactions 1 May 16, 2024
4 Insider transactions 1 May 16, 2024
8-k 8K-related 15 May 13, 2024
4 Insider transactions 1 May 13, 2024
10-q Quarterly Reports 68 May 13, 2024
4 Insider transactions 1 May 13, 2024
8-k 8K-related 18 Apr 17, 2024
ars Annual reports 1 Apr 15, 2024
def Proxies and info statements 22 Apr 11, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.